The most effective treatments are often out of reach for patients. Big news came from the FDA announcing the approval of CAR-T therapies for multiple myeloma patients, but drug assessments from third-party groups are concerning. Will patients be able to access these life-saving treatments?
Multiple myeloma oncologist Dr. Rafael Fonseca highlights the benefits of CAR-T therapies, the future of these advanced technologies, and the impossible task of putting a dollar value on patient quality of life. We also hear from multiple myeloma patient and advocate Dale Hopkins on how designer drugs like CAR-T could be a game-changer for his treatment regimen.
Interim Director, Mayo Clinic Cancer Center
Rafael Fonseca, M.D., is the interim director of Mayo Clinic Cancer Center and the director for Innovation and Transformational Relationships at Mayo Clinic's Arizona campus.
Dr. Fonseca has a broad range of research interests, including clinical trials for the treatment of myeloma and related conditions, a better understanding of the genetics of myeloma and related conditions (including the clinical implications), new drug development (including harnessing the cells' metabolism to develop effective therapies), myeloma bone disease, pharmacoeconomics, and policy.
The cumulative research efforts of Dr. Fonseca's laboratory have led to a better understanding of myeloma and related diseases, and unlocked novel treatment options for patients and provided context for the pharmacoeconomic implications of new therapies.
The successful patient is one who can get what they need when they need it. We all know insurance slows us down, so why not take matters into your own hands. Our Navigator is an online tool that allows you to search a massive network of health-related resources using your zip code so you get local results. Get proactive and become a more successful patient right now at PatientsRisingConcierge.org
Have a question or comment about the show, want to suggest a show topic or share your story as a patient correspondent?
Drop us a line: firstname.lastname@example.org
The views and opinions expressed herein are those of the guest(s)/ author(s) and do not reflect the official policy or position of Patients Rising.